BMJ 1995;311:1117-1118 (28 October)

News

Controversy rages over new contraceptive data

About half of the three million women in Britain who use the combined oral contraceptive pill were advised by the Committee on Safety of Medicines last week to switch to another brand, amid controversy about the way in which the new information was released. Evidence suggesting that use of two of the newer "third generation progestogens"--gestodene and desogestrel--is associated with an increased risk of venous thromboembolism was presented to the committee two weeks ago. As a result it decided to recommend that all users of brands containing the newer progestogens--Femodene, Femodene ED, Minulet, Triadene, Tri-Minulet, Marvelon, and Mercilon--should be offered the choice of switching to another brand and that these brands should be contraindicated in women who have other risk factors for venous thromboembolism.

Presenting the committee's decision at a press conference last Thursday, its chairman, Professor Michael Rawlins, said that early results from the World Health Organisation's task force . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

The system works
A W Macara and I Bogle
BMJ 1996 312: 578. [Extract] [Full Text]

Committee's action has compromised continuing studies
M William L Davis, Michael Lewis, Linda De Caestecker, and Ronald Mann
BMJ 1995 311: 1639. [Extract] [Full Text]

Controversy over new data on oral contraceptives
A Rouse
BMJ 1995 311: 1228. [Extract] [Full Text]

GPs were swamped by calls
Sally Hope
BMJ 1995 311: 1228-1229. [Extract] [Full Text]

This article has been cited by other articles:

  • Hemminki, E. (1996). Oral contraceptives and breast cancer. BMJ 313: 63-64 [Full text]  
  • Macara, A W, Bogle, I (1996). The system works. BMJ 312: 578a-578 [Full text]  
  • McPherson, K. (1996). Third generation oral contraception and venous thromboembolism. BMJ 312: 68-69 [Full text]  
  • Armstrong, J L, Reid, M, Bigrigg, A (1995). Scare over oral contraceptives. BMJ 311: 1637-1637 [Full text]  
  • Davis, M W. L, Lewis, M., De Caestecker, L., Mann, R. (1995). Committee's action has compromised continuing studies. BMJ 311: 1639-1639 [Full text]  
  • Donnelly, R J (1995). Studies implicate only gestodene and desogestrel. BMJ 311: 1639b-1639 [Full text]  
  • Fay, E. (1995). Career choices for generation X. BMJ 311: 1228b-1228 [Full text]  
  • Rouse, A (1995). Controversy over new data on oral contraceptives. BMJ 311: 1228c-1228 [Full text]  
  • Hope, S. (1995). GPs were swamped by calls. BMJ 311: 1228d-1229 [Full text]  
  • Rawlins, M. (1995). Combined oral contraceptives and thromboembolism. BMJ 311: 1232a-1232 [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ